

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.83813904 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.83813904 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.83813904 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.83813904 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.83813904 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.83813904 |
| 7 | adhesion of symbiont to host cell (GO:0044650) | 4.80011555 |
| 8 | virion attachment to host cell (GO:0019062) | 4.80011555 |
| 9 | barbed-end actin filament capping (GO:0051016) | 4.56819382 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.42379670 |
| 11 | adhesion of symbiont to host (GO:0044406) | 4.30779097 |
| 12 | glycosphingolipid catabolic process (GO:0046479) | 4.13596684 |
| 13 | response to peptidoglycan (GO:0032494) | 3.92194805 |
| 14 | protein localization to endosome (GO:0036010) | 3.87947951 |
| 15 | macroautophagy (GO:0016236) | 3.87025412 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.84578715 |
| 17 | response to host immune response (GO:0052572) | 3.84578715 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.83566758 |
| 19 | low-density lipoprotein particle clearance (GO:0034383) | 3.82284316 |
| 20 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.79496394 |
| 21 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.79427508 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.78237791 |
| 23 | amino sugar catabolic process (GO:0046348) | 3.77599259 |
| 24 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.72773860 |
| 25 | regulation of cholesterol storage (GO:0010885) | 3.69082607 |
| 26 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.69079860 |
| 27 | glycolipid catabolic process (GO:0019377) | 3.68556499 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.66704497 |
| 29 | endodermal cell differentiation (GO:0035987) | 3.62950166 |
| 30 | I-kappaB phosphorylation (GO:0007252) | 3.61234482 |
| 31 | oligosaccharide catabolic process (GO:0009313) | 3.60451411 |
| 32 | positive regulation of extracellular matrix organization (GO:1903055) | 3.51130206 |
| 33 | skin morphogenesis (GO:0043589) | 3.48900252 |
| 34 | positive regulation of heat generation (GO:0031652) | 3.47940172 |
| 35 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.44787061 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37714432 |
| 37 | response to host (GO:0075136) | 3.37714432 |
| 38 | response to host defenses (GO:0052200) | 3.37714432 |
| 39 | glial cell migration (GO:0008347) | 3.32682873 |
| 40 | cell adhesion mediated by integrin (GO:0033627) | 3.30850853 |
| 41 | negative regulation of lipid storage (GO:0010888) | 3.30547270 |
| 42 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.30112156 |
| 43 | reactive oxygen species biosynthetic process (GO:1903409) | 3.24868061 |
| 44 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.21219966 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21179748 |
| 46 | regulation of early endosome to late endosome transport (GO:2000641) | 3.19887250 |
| 47 | mannose metabolic process (GO:0006013) | 3.19168555 |
| 48 | ceramide catabolic process (GO:0046514) | 3.16428082 |
| 49 | protein heterotrimerization (GO:0070208) | 3.15872183 |
| 50 | hyaluronan catabolic process (GO:0030214) | 3.15185338 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.14819021 |
| 52 | microglial cell activation (GO:0001774) | 3.14586831 |
| 53 | cell migration involved in heart development (GO:0060973) | 3.12500821 |
| 54 | modulation by symbiont of host cellular process (GO:0044068) | 3.12288215 |
| 55 | response to thyroid hormone (GO:0097066) | 3.11140755 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.10529417 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 3.10518460 |
| 58 | apoptotic cell clearance (GO:0043277) | 3.10313469 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 3.09763432 |
| 60 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.09337348 |
| 61 | decidualization (GO:0046697) | 3.07992298 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06491402 |
| 63 | regulation of macrophage chemotaxis (GO:0010758) | 3.06353650 |
| 64 | stress fiber assembly (GO:0043149) | 3.05467856 |
| 65 | collagen metabolic process (GO:0032963) | 3.03834187 |
| 66 | membrane lipid catabolic process (GO:0046466) | 3.02731473 |
| 67 | collagen catabolic process (GO:0030574) | 3.02632354 |
| 68 | regulation of interferon-alpha production (GO:0032647) | 3.00325565 |
| 69 | macrophage activation (GO:0042116) | 3.00171184 |
| 70 | respiratory burst (GO:0045730) | 2.98394019 |
| 71 | keratan sulfate catabolic process (GO:0042340) | 2.97900764 |
| 72 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.97260792 |
| 73 | regulation of extracellular matrix disassembly (GO:0010715) | 2.94535802 |
| 74 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.92868700 |
| 75 | pinocytosis (GO:0006907) | 2.92730766 |
| 76 | positive regulation of p38MAPK cascade (GO:1900745) | 2.90870160 |
| 77 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.90581242 |
| 78 | sphingolipid catabolic process (GO:0030149) | 2.89356033 |
| 79 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.87981937 |
| 80 | basic amino acid transport (GO:0015802) | 2.87645362 |
| 81 | basement membrane organization (GO:0071711) | 2.85900578 |
| 82 | response to magnesium ion (GO:0032026) | 2.83454893 |
| 83 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.82098401 |
| 84 | venous blood vessel morphogenesis (GO:0048845) | 2.81543693 |
| 85 | multicellular organismal catabolic process (GO:0044243) | 2.81074562 |
| 86 | positive regulation of lipid storage (GO:0010884) | 2.80742206 |
| 87 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.78038561 |
| 88 | phagosome maturation (GO:0090382) | 2.77182350 |
| 89 | neutrophil mediated immunity (GO:0002446) | 2.76005376 |
| 90 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.75449985 |
| 91 | regulation of mononuclear cell migration (GO:0071675) | 2.75056981 |
| 92 | negative regulation of interleukin-1 production (GO:0032692) | 2.73958878 |
| 93 | substrate-dependent cell migration (GO:0006929) | 2.73943231 |
| 94 | positive regulation of receptor recycling (GO:0001921) | 2.71048150 |
| 95 | adenosine receptor signaling pathway (GO:0001973) | 2.68623947 |
| 96 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.68273805 |
| 97 | protein retention in ER lumen (GO:0006621) | 2.67637963 |
| 98 | phospholipid homeostasis (GO:0055091) | 2.67508193 |
| 99 | regulation of heat generation (GO:0031650) | 2.67477859 |
| 100 | regulation of monocyte chemotaxis (GO:0090025) | 2.67395933 |
| 101 | extracellular matrix disassembly (GO:0022617) | 2.67144334 |
| 102 | positive regulation of cholesterol efflux (GO:0010875) | 2.66627594 |
| 103 | negative regulation of interleukin-12 production (GO:0032695) | 2.66124726 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.65713654 |
| 105 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.65684839 |
| 106 | embryo implantation (GO:0007566) | 2.65295474 |
| 107 | multicellular organismal metabolic process (GO:0044236) | 2.64537776 |
| 108 | regulation of fever generation (GO:0031620) | 2.63762598 |
| 109 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.63430762 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.63236483 |
| 111 | detection of biotic stimulus (GO:0009595) | 2.62026142 |
| 112 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.61359738 |
| 113 | regulation of lipid storage (GO:0010883) | 2.60984967 |
| 114 | chondroitin sulfate catabolic process (GO:0030207) | 2.60803647 |
| 115 | lipoprotein transport (GO:0042953) | 2.58604641 |
| 116 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.58559172 |
| 117 | protein carboxylation (GO:0018214) | 2.58559172 |
| 118 | regulation of extracellular matrix organization (GO:1903053) | 2.57867274 |
| 119 | wound healing, spreading of epidermal cells (GO:0035313) | 2.57500833 |
| 120 | regulation of cellular amide metabolic process (GO:0034248) | 2.56802304 |
| 121 | natural killer cell mediated immunity (GO:0002228) | 2.55816921 |
| 122 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.55816921 |
| 123 | negative regulation of interleukin-17 production (GO:0032700) | 2.54234552 |
| 124 | semaphorin-plexin signaling pathway (GO:0071526) | 2.53510251 |
| 125 | response to acidic pH (GO:0010447) | 2.52922792 |
| 126 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.51650202 |
| 127 | cortical actin cytoskeleton organization (GO:0030866) | 2.51201137 |
| 128 | type B pancreatic cell proliferation (GO:0044342) | 2.48668584 |
| 129 | granulocyte activation (GO:0036230) | 2.47754644 |
| 130 | regulation of integrin activation (GO:0033623) | 2.47754063 |
| 131 | response to lipoprotein particle (GO:0055094) | 2.46943631 |
| 132 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.46637788 |
| 133 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.46358069 |
| 134 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.46236942 |
| 135 | positive regulation of axon extension (GO:0045773) | 2.45814683 |
| 136 | endothelial cell chemotaxis (GO:0035767) | 2.44958044 |
| 137 | cell-cell junction maintenance (GO:0045217) | 2.42861389 |
| 138 | positive regulation of antigen processing and presentation (GO:0002579) | 2.41630714 |
| 139 | positive regulation of leukocyte degranulation (GO:0043302) | 2.41585155 |
| 140 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.41522419 |
| 141 | regulation of smooth muscle cell migration (GO:0014910) | 2.40969232 |
| 142 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.40933392 |
| 143 | cytokine secretion (GO:0050663) | 2.40919707 |
| 144 | eosinophil chemotaxis (GO:0048245) | 2.40336664 |
| 145 | Golgi transport vesicle coating (GO:0048200) | 2.39089497 |
| 146 | COPI coating of Golgi vesicle (GO:0048205) | 2.39089497 |
| 147 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.38811611 |
| 148 | epithelial cell-cell adhesion (GO:0090136) | 2.38673944 |
| 149 | superoxide anion generation (GO:0042554) | 2.38434754 |
| 150 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.38236151 |
| 151 | collagen fibril organization (GO:0030199) | 2.37142435 |
| 152 | positive regulation of fat cell differentiation (GO:0045600) | 2.37010255 |
| 153 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.36959300 |
| 154 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.36676861 |
| 155 | cortical cytoskeleton organization (GO:0030865) | 2.36251183 |
| 156 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.34619177 |
| 157 | positive regulation of phagocytosis (GO:0050766) | 2.34281292 |
| 158 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.34278816 |
| 159 | regulation of apoptotic cell clearance (GO:2000425) | 2.33830069 |
| 160 | endocytic recycling (GO:0032456) | 2.33749688 |
| 161 | negative regulation of focal adhesion assembly (GO:0051895) | 2.33688909 |
| 162 | negative regulation of cell junction assembly (GO:1901889) | 2.33688909 |
| 163 | negative regulation of adherens junction organization (GO:1903392) | 2.33688909 |
| 164 | fibril organization (GO:0097435) | 2.32947408 |
| 165 | chondrocyte proliferation (GO:0035988) | 2.32923977 |
| 166 | response to laminar fluid shear stress (GO:0034616) | 2.31539368 |
| 167 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.31456654 |
| 168 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.30702854 |
| 169 | angiotensin maturation (GO:0002003) | 2.29893428 |
| 170 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.29555240 |
| 171 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.29202783 |
| 172 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.28574353 |
| 173 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.28574353 |
| 174 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.28331129 |
| 175 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.28308704 |
| 176 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.26655093 |
| 177 | complement activation, alternative pathway (GO:0006957) | 2.26551870 |
| 178 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.25917431 |
| 179 | positive regulation of interferon-beta production (GO:0032728) | 2.25207581 |
| 180 | alpha-linolenic acid metabolic process (GO:0036109) | 2.24668461 |
| 181 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.23477195 |
| 182 | regulation of chemokine biosynthetic process (GO:0045073) | 2.19319082 |
| 183 | interaction with host (GO:0051701) | 2.19174719 |
| 184 | intracellular pH reduction (GO:0051452) | 2.18958507 |
| 185 | cellular response to nicotine (GO:0071316) | 2.18707905 |
| 186 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.18139505 |
| 187 | L-phenylalanine catabolic process (GO:0006559) | 2.18139505 |
| 188 | regulation of cholesterol homeostasis (GO:2000188) | 2.18059602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47876724 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.37054765 |
| 3 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.88118797 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.53320753 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34688734 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19399924 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07188731 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99964164 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86688567 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.73746139 |
| 11 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66317633 |
| 12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.41654777 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32790416 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29478818 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25190887 |
| 16 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.16349551 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04896343 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92185540 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84762754 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84303081 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79818790 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79755380 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78983981 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78672098 |
| 25 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.74497285 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.67691226 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67611735 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.66849094 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64889540 |
| 30 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.63916753 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63349747 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62136951 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61848549 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60048547 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58725337 |
| 36 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.57259270 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54453590 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53759840 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51855400 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51246642 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50544387 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50425317 |
| 43 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50290640 |
| 44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47186533 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46759556 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44811079 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.42905092 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42697870 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41124358 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38653856 |
| 51 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37960788 |
| 52 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34772368 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33966689 |
| 54 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33719057 |
| 55 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.32451694 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32100738 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31135207 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29721946 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29353802 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28047285 |
| 61 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27697627 |
| 62 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26981481 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26697284 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26660438 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26660438 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24702745 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23339674 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22690078 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21140827 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20991437 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.17908308 |
| 72 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.17005761 |
| 73 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16958452 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16140071 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15917072 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15470463 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15184475 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14760272 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14500983 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13935601 |
| 81 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.13467439 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13414409 |
| 83 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12494956 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12054474 |
| 85 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10397863 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10041924 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09431251 |
| 88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09366972 |
| 89 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09032700 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08016828 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07750228 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07436608 |
| 93 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05920090 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05318533 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05113669 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04928704 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03933544 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02943188 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02943188 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02744453 |
| 101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01202114 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00017037 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99780850 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98854717 |
| 105 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97993144 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97127509 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96589833 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94572262 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94261765 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93111926 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92492909 |
| 112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92192162 |
| 113 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91686096 |
| 114 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91588250 |
| 115 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91459553 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91381113 |
| 117 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.90808416 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88562524 |
| 119 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88350625 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88043080 |
| 121 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88022408 |
| 122 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87855092 |
| 123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.87538206 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85679410 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84538083 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83423414 |
| 127 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82544597 |
| 128 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81055657 |
| 129 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.79925162 |
| 130 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77436047 |
| 131 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77376764 |
| 132 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76714263 |
| 133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76498550 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75838805 |
| 135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75316822 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75154110 |
| 137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74321439 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73936390 |
| 139 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.71707453 |
| 140 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71408870 |
| 141 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.69412071 |
| 142 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.69097820 |
| 143 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.69004962 |
| 144 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68771265 |
| 145 | GATA3_26560356_Chip-Seq_TH2_Human | 0.68223951 |
| 146 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.64971785 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64713253 |
| 148 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64082225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.44286366 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.28248109 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.69473058 |
| 4 | MP0003303_peritoneal_inflammation | 3.31771096 |
| 5 | MP0003279_aneurysm | 3.01208810 |
| 6 | MP0009840_abnormal_foam_cell | 2.93475611 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.92256353 |
| 8 | MP0003195_calcinosis | 2.84731741 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.80460356 |
| 10 | MP0003436_decreased_susceptibility_to | 2.79440779 |
| 11 | MP0005083_abnormal_biliary_tract | 2.44988975 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.42962928 |
| 13 | MP0000604_amyloidosis | 2.36520611 |
| 14 | MP0002419_abnormal_innate_immunity | 2.33378293 |
| 15 | MP0005360_urolithiasis | 2.30151179 |
| 16 | MP0006054_spinal_hemorrhage | 2.22576031 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.16596136 |
| 18 | MP0006082_CNS_inflammation | 2.15881213 |
| 19 | MP0005503_abnormal_tendon_morphology | 2.08764287 |
| 20 | MP0004510_myositis | 2.08220886 |
| 21 | MP0009278_abnormal_bone_marrow | 2.04095186 |
| 22 | MP0001542_abnormal_bone_strength | 2.03719379 |
| 23 | MP0005365_abnormal_bile_salt | 1.97482303 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.96356697 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.94560517 |
| 26 | MP0004272_abnormal_basement_membrane | 1.93003274 |
| 27 | MP0009785_altered_susceptibility_to | 1.80203246 |
| 28 | MP0005387_immune_system_phenotype | 1.74407092 |
| 29 | MP0001790_abnormal_immune_system | 1.74407092 |
| 30 | MP0004947_skin_inflammation | 1.73246210 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.73056313 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.71777663 |
| 33 | MP0005023_abnormal_wound_healing | 1.71024784 |
| 34 | MP0001849_ear_inflammation | 1.68531559 |
| 35 | MP0005025_abnormal_response_to | 1.68454104 |
| 36 | MP0005275_abnormal_skin_tensile | 1.68378014 |
| 37 | MP0004858_abnormal_nervous_system | 1.67562504 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.67379526 |
| 39 | MP0003690_abnormal_glial_cell | 1.63554680 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.61677970 |
| 41 | MP0002896_abnormal_bone_mineralization | 1.60122169 |
| 42 | MP0003075_altered_response_to | 1.59747463 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.55921030 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.54017302 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.53982614 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.51896751 |
| 47 | MP0003724_increased_susceptibility_to | 1.51055647 |
| 48 | MP0000767_abnormal_smooth_muscle | 1.49023244 |
| 49 | MP0000751_myopathy | 1.44012240 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.42760724 |
| 51 | MP0005451_abnormal_body_composition | 1.42574466 |
| 52 | MP0002254_reproductive_system_inflammat | 1.41791913 |
| 53 | MP0005595_abnormal_vascular_smooth | 1.39585448 |
| 54 | MP0008469_abnormal_protein_level | 1.39504951 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.39004567 |
| 56 | MP0005508_abnormal_skeleton_morphology | 1.38153251 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.35402526 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.33968891 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.33063343 |
| 60 | MP0000920_abnormal_myelination | 1.32689945 |
| 61 | MP0002693_abnormal_pancreas_physiology | 1.31396642 |
| 62 | MP0005390_skeleton_phenotype | 1.31156695 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.29608714 |
| 64 | MP0000858_altered_metastatic_potential | 1.28779677 |
| 65 | MP0009764_decreased_sensitivity_to | 1.28306210 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.25930831 |
| 67 | MP0004130_abnormal_muscle_cell | 1.25497147 |
| 68 | MP0003252_abnormal_bile_duct | 1.24395508 |
| 69 | MP0000685_abnormal_immune_system | 1.24256617 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.23801285 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.22379690 |
| 72 | MP0002723_abnormal_immune_serum | 1.21837428 |
| 73 | MP0009384_cardiac_valve_regurgitation | 1.21373948 |
| 74 | MP0000609_abnormal_liver_physiology | 1.17400705 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.16772137 |
| 76 | MP0003448_altered_tumor_morphology | 1.15255978 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 1.14882915 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 1.12392472 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 1.09300855 |
| 80 | MP0008260_abnormal_autophagy | 1.09162012 |
| 81 | MP0000371_diluted_coat_color | 1.08416174 |
| 82 | MP0005332_abnormal_amino_acid | 1.07900328 |
| 83 | MP0001800_abnormal_humoral_immune | 1.05495107 |
| 84 | MP0001243_abnormal_dermal_layer | 1.05411854 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.05382297 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 1.05000669 |
| 87 | MP0005165_increased_susceptibility_to | 1.04818006 |
| 88 | MP0001853_heart_inflammation | 1.03973739 |
| 89 | MP0001756_abnormal_urination | 1.02194000 |
| 90 | MP0002933_joint_inflammation | 1.02091895 |
| 91 | MP0005166_decreased_susceptibility_to | 1.02009622 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 1.01004345 |
| 93 | MP0002060_abnormal_skin_morphology | 1.00132822 |
| 94 | MP0009763_increased_sensitivity_to | 0.99213996 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.96912301 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.96899566 |
| 97 | MP0000343_altered_response_to | 0.95873140 |
| 98 | MP0005535_abnormal_body_temperature | 0.94437719 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.93893632 |
| 100 | MP0003828_pulmonary_edema | 0.93632780 |
| 101 | MP0003329_amyloid_beta_deposits | 0.92024424 |
| 102 | MP0001819_abnormal_immune_cell | 0.91883907 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.89039745 |
| 104 | MP0002420_abnormal_adaptive_immunity | 0.88341728 |
| 105 | MP0004019_abnormal_vitamin_homeostasis | 0.88321738 |
| 106 | MP0004883_abnormal_blood_vessel | 0.86111879 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.86060625 |
| 108 | MP0005448_abnormal_energy_balance | 0.85124144 |
| 109 | MP0001958_emphysema | 0.85026711 |
| 110 | MP0001881_abnormal_mammary_gland | 0.83978635 |
| 111 | MP0000747_muscle_weakness | 0.83142489 |
| 112 | MP0003634_abnormal_glial_cell | 0.82914589 |
| 113 | MP0004043_abnormal_pH_regulation | 0.81640991 |
| 114 | MP0010368_abnormal_lymphatic_system | 0.80667179 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.79870035 |
| 116 | MP0001915_intracranial_hemorrhage | 0.78643359 |
| 117 | MP0003091_abnormal_cell_migration | 0.78447948 |
| 118 | MP0002405_respiratory_system_inflammati | 0.77841282 |
| 119 | MP0002090_abnormal_vision | 0.77759381 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.77482026 |
| 121 | MP0005310_abnormal_salivary_gland | 0.76667174 |
| 122 | MP0000249_abnormal_blood_vessel | 0.76342807 |
| 123 | MP0003950_abnormal_plasma_membrane | 0.75006300 |
| 124 | MP0002113_abnormal_skeleton_development | 0.74391363 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74061817 |
| 126 | MP0001545_abnormal_hematopoietic_system | 0.72797101 |
| 127 | MP0005397_hematopoietic_system_phenotyp | 0.72797101 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.72030824 |
| 129 | MP0005164_abnormal_response_to | 0.71668791 |
| 130 | MP0003283_abnormal_digestive_organ | 0.71089465 |
| 131 | MP0008004_abnormal_stomach_pH | 0.71042282 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.70122750 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.69908948 |
| 134 | MP0000733_abnormal_muscle_development | 0.69885684 |
| 135 | MP0002928_abnormal_bile_duct | 0.69843967 |
| 136 | MP0003879_abnormal_hair_cell | 0.69383934 |
| 137 | MP0003795_abnormal_bone_structure | 0.68440821 |
| 138 | MP0002168_other_aberrant_phenotype | 0.68434324 |
| 139 | MP0008874_decreased_physiological_sensi | 0.68090443 |
| 140 | MP0000681_abnormal_thyroid_gland | 0.64844257 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.63088061 |
| 142 | MP0000163_abnormal_cartilage_morphology | 0.62983539 |
| 143 | MP0004233_abnormal_muscle_weight | 0.62912730 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.61307513 |
| 145 | MP0002115_abnormal_skeleton_extremities | 0.59558669 |
| 146 | MP0009053_abnormal_anal_canal | 0.57158979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.26468600 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.11285671 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 4.95902218 |
| 4 | Premature rupture of membranes (HP:0001788) | 4.88126495 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.85224590 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.73115671 |
| 7 | Protrusio acetabuli (HP:0003179) | 4.47552042 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.31572208 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.28329196 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.20244019 |
| 11 | Stomatitis (HP:0010280) | 4.02473719 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.00905593 |
| 13 | Mucopolysacchariduria (HP:0008155) | 4.00905593 |
| 14 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.92218645 |
| 15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.92218645 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.92218645 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.89426605 |
| 18 | Axonal loss (HP:0003447) | 3.85882169 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.73577096 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.73577096 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.73577096 |
| 22 | Amyloidosis (HP:0011034) | 3.64038725 |
| 23 | Gingivitis (HP:0000230) | 3.51146581 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.47636031 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.41010511 |
| 26 | Ankle contracture (HP:0006466) | 3.32986145 |
| 27 | Nuclear cataract (HP:0100018) | 3.27148682 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07322277 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.01660297 |
| 30 | Cerebral aneurysm (HP:0004944) | 3.01614456 |
| 31 | Joint hemorrhage (HP:0005261) | 3.00071075 |
| 32 | Glomerulonephritis (HP:0000099) | 2.96052274 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 2.93365100 |
| 34 | Myocardial infarction (HP:0001658) | 2.91857856 |
| 35 | Cervical subluxation (HP:0003308) | 2.88533334 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.86718883 |
| 37 | Recurrent skin infections (HP:0001581) | 2.77086169 |
| 38 | Xanthomatosis (HP:0000991) | 2.77024681 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.76714157 |
| 40 | Spinal rigidity (HP:0003306) | 2.76234658 |
| 41 | Bladder diverticulum (HP:0000015) | 2.74393527 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.71591889 |
| 43 | Vascular tortuosity (HP:0004948) | 2.67924621 |
| 44 | Global brain atrophy (HP:0002283) | 2.67580959 |
| 45 | Achilles tendon contracture (HP:0001771) | 2.67331892 |
| 46 | Complement deficiency (HP:0004431) | 2.67049238 |
| 47 | Atrophic scars (HP:0001075) | 2.62376021 |
| 48 | Pathologic fracture (HP:0002756) | 2.62273196 |
| 49 | Retinal atrophy (HP:0001105) | 2.61005141 |
| 50 | Slender build (HP:0001533) | 2.59848290 |
| 51 | Tetraparesis (HP:0002273) | 2.59753020 |
| 52 | Mutism (HP:0002300) | 2.58550164 |
| 53 | Aortic dissection (HP:0002647) | 2.56548129 |
| 54 | Loss of speech (HP:0002371) | 2.56518052 |
| 55 | Spondylolisthesis (HP:0003302) | 2.54888578 |
| 56 | Periodontitis (HP:0000704) | 2.54164683 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.50915634 |
| 58 | Follicular hyperkeratosis (HP:0007502) | 2.48477362 |
| 59 | Thick nail (HP:0001805) | 2.46662282 |
| 60 | Aortic aneurysm (HP:0004942) | 2.45838911 |
| 61 | Abnormality of the Achilles tendon (HP:0005109) | 2.44553449 |
| 62 | Peripheral demyelination (HP:0011096) | 2.39682734 |
| 63 | Disinhibition (HP:0000734) | 2.38323795 |
| 64 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.37907346 |
| 65 | Arterial tortuosity (HP:0005116) | 2.35586017 |
| 66 | Increased CSF protein (HP:0002922) | 2.33088550 |
| 67 | Genu recurvatum (HP:0002816) | 2.32671555 |
| 68 | Bone pain (HP:0002653) | 2.32554527 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.32454770 |
| 70 | Hypoglycemic coma (HP:0001325) | 2.32364676 |
| 71 | Skin nodule (HP:0200036) | 2.32162995 |
| 72 | Joint stiffness (HP:0001387) | 2.31125739 |
| 73 | Premature loss of primary teeth (HP:0006323) | 2.29714447 |
| 74 | Abnormality of the common coagulation pathway (HP:0010990) | 2.29007833 |
| 75 | Fragile skin (HP:0001030) | 2.28222508 |
| 76 | Urticaria (HP:0001025) | 2.28186718 |
| 77 | Abnormality of complement system (HP:0005339) | 2.27902266 |
| 78 | Shallow orbits (HP:0000586) | 2.27385682 |
| 79 | Frequent falls (HP:0002359) | 2.27353499 |
| 80 | Distal upper limb amyotrophy (HP:0007149) | 2.25443245 |
| 81 | Upper limb amyotrophy (HP:0009129) | 2.25443245 |
| 82 | Hyperacusis (HP:0010780) | 2.24234903 |
| 83 | Wormian bones (HP:0002645) | 2.23770202 |
| 84 | Apathy (HP:0000741) | 2.23428948 |
| 85 | Increased connective tissue (HP:0009025) | 2.23094718 |
| 86 | Blue sclerae (HP:0000592) | 2.22843349 |
| 87 | Thin bony cortex (HP:0002753) | 2.21875508 |
| 88 | Orchitis (HP:0100796) | 2.21364082 |
| 89 | Hypercholesterolemia (HP:0003124) | 2.21017742 |
| 90 | Broad metatarsal (HP:0001783) | 2.20957664 |
| 91 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.20342171 |
| 92 | J-shaped sella turcica (HP:0002680) | 2.19586876 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.18372549 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 2.18372549 |
| 95 | Supranuclear gaze palsy (HP:0000605) | 2.17624798 |
| 96 | Ketoacidosis (HP:0001993) | 2.16369679 |
| 97 | Diminished motivation (HP:0000745) | 2.16219151 |
| 98 | Soft skin (HP:0000977) | 2.15998704 |
| 99 | Protuberant abdomen (HP:0001538) | 2.15402767 |
| 100 | Deep venous thrombosis (HP:0002625) | 2.14898002 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 2.12642373 |
| 102 | Episodic fever (HP:0001954) | 2.12067165 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 2.11690669 |
| 104 | Prolonged partial thromboplastin time (HP:0003645) | 2.10291965 |
| 105 | Abnormality of dentin (HP:0010299) | 2.08014874 |
| 106 | Nephritis (HP:0000123) | 2.07559191 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06856802 |
| 108 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05020508 |
| 109 | Mitral stenosis (HP:0001718) | 2.05004577 |
| 110 | Purpura (HP:0000979) | 2.04798904 |
| 111 | Dilatation of the ascending aorta (HP:0005111) | 2.04275607 |
| 112 | * Hypophosphatemia (HP:0002148) | 2.04034125 |
| 113 | Epidermoid cyst (HP:0200040) | 2.03685246 |
| 114 | Gingival bleeding (HP:0000225) | 2.03453123 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 2.01487984 |
| 116 | Progressive sensorineural hearing impairment (HP:0000408) | 2.00628328 |
| 117 | Aneurysm (HP:0002617) | 1.99984947 |
| 118 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.97732556 |
| 119 | Symptomatic seizures (HP:0011145) | 1.97317477 |
| 120 | Mitral regurgitation (HP:0001653) | 1.96925298 |
| 121 | Conjugated hyperbilirubinemia (HP:0002908) | 1.96654057 |
| 122 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96413616 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.95637920 |
| 124 | Asymmetric septal hypertrophy (HP:0001670) | 1.95478710 |
| 125 | Vasculitis (HP:0002633) | 1.94823954 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 1.94789863 |
| 127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94789863 |
| 128 | Optic neuritis (HP:0100653) | 1.94665820 |
| 129 | Retrobulbar optic neuritis (HP:0100654) | 1.94665820 |
| 130 | Hyperlipoproteinemia (HP:0010980) | 1.94474563 |
| 131 | Distal lower limb muscle weakness (HP:0009053) | 1.93692743 |
| 132 | Peritonitis (HP:0002586) | 1.93056941 |
| 133 | Neuronal loss in central nervous system (HP:0002529) | 1.92400150 |
| 134 | Generalized amyotrophy (HP:0003700) | 1.91360159 |
| 135 | Abnormality of the intrinsic pathway (HP:0010989) | 1.91015157 |
| 136 | Ketosis (HP:0001946) | 1.90323406 |
| 137 | Elbow flexion contracture (HP:0002987) | 1.89982200 |
| 138 | Obstructive sleep apnea (HP:0002870) | 1.89696065 |
| 139 | Progressive hearing impairment (HP:0001730) | 1.88204174 |
| 140 | Hematochezia (HP:0002573) | 1.88007596 |
| 141 | Myositis (HP:0100614) | 1.87286124 |
| 142 | Abdominal distention (HP:0003270) | 1.86553008 |
| 143 | Bowel diverticulosis (HP:0005222) | 1.86305171 |
| 144 | Abnormality of vision evoked potentials (HP:0000649) | 1.85643648 |
| 145 | Basal ganglia calcification (HP:0002135) | 1.85267778 |
| 146 | Neonatal short-limb short stature (HP:0008921) | 1.84955562 |
| 147 | Hand muscle atrophy (HP:0009130) | 1.84882420 |
| 148 | Recurrent fungal infections (HP:0002841) | 1.84427850 |
| 149 | Hyperglycemia (HP:0003074) | 1.82382443 |
| 150 | Short nail (HP:0001799) | 1.82092643 |
| 151 | Slow saccadic eye movements (HP:0000514) | 1.81719204 |
| 152 | Thoracic kyphosis (HP:0002942) | 1.81146463 |
| 153 | Distal lower limb amyotrophy (HP:0008944) | 1.80656428 |
| 154 | Menorrhagia (HP:0000132) | 1.80356431 |
| 155 | Neurofibrillary tangles (HP:0002185) | 1.79195477 |
| 156 | Prolonged neonatal jaundice (HP:0006579) | 1.78237972 |
| 157 | Intrahepatic cholestasis (HP:0001406) | 1.77307844 |
| 158 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76947745 |
| 159 | Biconcave vertebral bodies (HP:0004586) | 1.76863771 |
| 160 | Pulmonary infiltrates (HP:0002113) | 1.76085217 |
| 161 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75760289 |
| 162 | Progressive neurologic deterioration (HP:0002344) | 1.74880830 |
| 163 | Hyperextensible skin (HP:0000974) | 1.74866685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.75130478 |
| 2 | IRAK3 | 3.68177501 |
| 3 | ERN1 | 3.44429942 |
| 4 | DDR2 | 3.33868860 |
| 5 | MAP3K14 | 3.29957282 |
| 6 | TGFBR2 | 2.94931175 |
| 7 | DAPK2 | 2.93693082 |
| 8 | NME2 | 2.89560368 |
| 9 | TBK1 | 2.87790439 |
| 10 | TAOK3 | 2.79643268 |
| 11 | INSRR | 2.56508203 |
| 12 | TYK2 | 2.30086622 |
| 13 | TESK1 | 2.29772175 |
| 14 | EPHB2 | 2.06936742 |
| 15 | IKBKE | 2.03107657 |
| 16 | LIMK1 | 2.01604543 |
| 17 | CDC42BPA | 1.96149710 |
| 18 | SIK1 | 1.95461049 |
| 19 | IRAK4 | 1.94368642 |
| 20 | GRK7 | 1.91732399 |
| 21 | TRIB3 | 1.83961302 |
| 22 | LATS2 | 1.83596200 |
| 23 | JAK1 | 1.82509983 |
| 24 | MAP3K13 | 1.74362383 |
| 25 | KIT | 1.73048368 |
| 26 | PRPF4B | 1.70332800 |
| 27 | TAOK2 | 1.68904663 |
| 28 | PTK6 | 1.66770766 |
| 29 | BLK | 1.65072548 |
| 30 | MOS | 1.65060681 |
| 31 | CAMK1D | 1.58854608 |
| 32 | MAPK15 | 1.58189342 |
| 33 | RIPK1 | 1.56563390 |
| 34 | MYLK | 1.55205296 |
| 35 | SIK2 | 1.54736389 |
| 36 | ICK | 1.49827079 |
| 37 | CAMK1G | 1.45724871 |
| 38 | PAK4 | 1.42173190 |
| 39 | PIM2 | 1.39395144 |
| 40 | JAK3 | 1.38586062 |
| 41 | MAP3K11 | 1.36601353 |
| 42 | MAP3K2 | 1.30541135 |
| 43 | IKBKB | 1.28364904 |
| 44 | MAP2K3 | 1.27651964 |
| 45 | MST1R | 1.25634258 |
| 46 | PRKD2 | 1.22715852 |
| 47 | ARAF | 1.21950030 |
| 48 | JAK2 | 1.18866385 |
| 49 | WNK3 | 1.17946109 |
| 50 | CSK | 1.16881263 |
| 51 | TTN | 1.16765458 |
| 52 | CHUK | 1.15635434 |
| 53 | PAK2 | 1.12275167 |
| 54 | TYRO3 | 1.06553970 |
| 55 | FGFR4 | 1.05540817 |
| 56 | TAOK1 | 1.00474014 |
| 57 | HCK | 0.97376863 |
| 58 | MAP3K3 | 0.95476380 |
| 59 | FGR | 0.95185704 |
| 60 | ERBB4 | 0.93599228 |
| 61 | ZAP70 | 0.93557206 |
| 62 | FES | 0.90354553 |
| 63 | MAP3K6 | 0.90336011 |
| 64 | KSR2 | 0.89974134 |
| 65 | ABL2 | 0.89238711 |
| 66 | DAPK3 | 0.87385109 |
| 67 | DAPK1 | 0.87035080 |
| 68 | NTRK1 | 0.86773150 |
| 69 | TESK2 | 0.84764399 |
| 70 | CAMKK2 | 0.83558224 |
| 71 | EGFR | 0.81692915 |
| 72 | SYK | 0.80899967 |
| 73 | MAP3K1 | 0.80757499 |
| 74 | HIPK2 | 0.79411098 |
| 75 | BMX | 0.75519621 |
| 76 | MATK | 0.75064745 |
| 77 | EPHB1 | 0.74446149 |
| 78 | MAPK7 | 0.73726159 |
| 79 | MAP3K9 | 0.71834953 |
| 80 | PIK3CG | 0.69497237 |
| 81 | CAMKK1 | 0.69400998 |
| 82 | PINK1 | 0.68651510 |
| 83 | MARK2 | 0.68134402 |
| 84 | SMG1 | 0.66340513 |
| 85 | PDGFRB | 0.66191251 |
| 86 | MAP3K10 | 0.65925193 |
| 87 | PTK2 | 0.65825733 |
| 88 | SCYL2 | 0.65732203 |
| 89 | ROCK2 | 0.64493986 |
| 90 | PRKCH | 0.63731800 |
| 91 | DMPK | 0.61481812 |
| 92 | CSF1R | 0.60919081 |
| 93 | PDPK1 | 0.60802712 |
| 94 | PKN2 | 0.60757423 |
| 95 | CAMK2G | 0.60255026 |
| 96 | PDGFRA | 0.58498045 |
| 97 | LYN | 0.57563084 |
| 98 | LCK | 0.57044855 |
| 99 | SIK3 | 0.56794806 |
| 100 | RPS6KA6 | 0.56663492 |
| 101 | MAPK4 | 0.56481628 |
| 102 | RPS6KA2 | 0.56217290 |
| 103 | TXK | 0.56067193 |
| 104 | DYRK1B | 0.55134192 |
| 105 | RPS6KC1 | 0.54724813 |
| 106 | RPS6KL1 | 0.54724813 |
| 107 | MAP4K1 | 0.54532924 |
| 108 | ADRBK2 | 0.54205326 |
| 109 | ERBB2 | 0.52257536 |
| 110 | FYN | 0.51725961 |
| 111 | GSK3A | 0.51275351 |
| 112 | PRKCD | 0.50769819 |
| 113 | ROCK1 | 0.49979732 |
| 114 | MARK3 | 0.49813609 |
| 115 | SGK1 | 0.48854842 |
| 116 | ABL1 | 0.48202420 |
| 117 | IRAK2 | 0.48183838 |
| 118 | LMTK2 | 0.46775967 |
| 119 | NEK9 | 0.46573510 |
| 120 | RPS6KA4 | 0.46024875 |
| 121 | STK38 | 0.45939510 |
| 122 | TGFBR1 | 0.45053313 |
| 123 | MAPK12 | 0.44807151 |
| 124 | SGK3 | 0.44687127 |
| 125 | FGFR3 | 0.44428800 |
| 126 | BRAF | 0.44286962 |
| 127 | MTOR | 0.43669521 |
| 128 | MAP3K5 | 0.40885124 |
| 129 | BCKDK | 0.40060462 |
| 130 | IGF1R | 0.39306116 |
| 131 | MARK1 | 0.39297584 |
| 132 | FRK | 0.38895365 |
| 133 | IRAK1 | 0.38410279 |
| 134 | CDK6 | 0.37906009 |
| 135 | PRKCZ | 0.37608708 |
| 136 | RET | 0.37513990 |
| 137 | PRKCE | 0.37164124 |
| 138 | PAK1 | 0.37137318 |
| 139 | MET | 0.36845765 |
| 140 | SRC | 0.36712269 |
| 141 | CDK15 | 0.36628622 |
| 142 | PRKD3 | 0.36342898 |
| 143 | PRKD1 | 0.36299191 |
| 144 | CAMK2B | 0.36284313 |
| 145 | PRKG2 | 0.34588941 |
| 146 | PAK6 | 0.34017684 |
| 147 | MAP3K8 | 0.33825721 |
| 148 | CDK11A | 0.32821724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.90020697 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.74410378 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.37860197 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.28580731 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11986699 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00309389 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.92943009 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86679940 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 1.79423041 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 1.78171093 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76502244 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73123321 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68582744 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67424651 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.66920223 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.66853979 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62974085 |
| 18 | Bladder cancer_Homo sapiens_hsa05219 | 1.60488038 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.60235434 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.60022716 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54241030 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.45348891 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.42188823 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.33985217 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32400979 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.32298219 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31008428 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24267242 |
| 29 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20490192 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19094730 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.18915098 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11830968 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11384581 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09037579 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06616423 |
| 36 | Insulin resistance_Homo sapiens_hsa04931 | 1.03061719 |
| 37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00628936 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.00051835 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99536390 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 0.99041381 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97277697 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95185174 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95036159 |
| 44 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94386089 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94276001 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94243746 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.92307228 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91297363 |
| 49 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91205719 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.91072645 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90853281 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.87758758 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87682565 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85884124 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84345196 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81735175 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80431218 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80071587 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.79727349 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79685287 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.79675102 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79626622 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78662216 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78580675 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76458119 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76031092 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75463004 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.75271758 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74893492 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73740104 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73615508 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.73424931 |
| 73 | Measles_Homo sapiens_hsa05162 | 0.73390597 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.73020553 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71453311 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71217128 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70532319 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68530220 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68180601 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66756753 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.65821433 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65453299 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64530291 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.63457718 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62123984 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60831446 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60417740 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60058919 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59813178 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58878449 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58416313 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58061693 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57654070 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56531577 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56061254 |
| 96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56025576 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54999084 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53643842 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53171214 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52875332 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52843632 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.51429288 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51273018 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.50570306 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49842239 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49820742 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.49349535 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.48784544 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48727930 |
| 110 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48581514 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.48552329 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48293147 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47948248 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46279018 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45407955 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44238073 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44062827 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.43759521 |
| 119 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43512286 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43079995 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43044742 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43026731 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41345330 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41209366 |
| 125 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40317801 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.40201001 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40155321 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39679830 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39534087 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39459167 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37612616 |
| 132 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36455822 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36028061 |
| 134 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35896156 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35881427 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35603275 |
| 137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35242332 |
| 138 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34383411 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.34077846 |
| 140 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33853463 |
| 141 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33430672 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33429328 |

